Back to Search
ROBERT PADERA, MD PHD
MD PHD
Anatomic Pathology Physician
NPI: 1679509640IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anatomic Pathology PhysicianPrimary
Pathology — Anatomic Pathology
Code: 207ZP0101X
219064(MA)
CMS Specialties
PrimaryPATHOLOGY
Education
HARVARD MEDICAL SCHOOL
Class of 2000
Research & Publications (20)
Local myotoxicity from sustained release of bupivacaine from microparticles.
PMID 18431129·Anesthesiology·2008
7-preclinical
Tetrodotoxin for prolonged local anesthesia with minimal myotoxicity.
PMID 16897761·Muscle Nerve·2006
7-preclinical
Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice.
PMID 19118250·Circulation·2009
4-observational
HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy.
PMID 19122144·Proc Natl Acad Sci U S A·2009
7-preclinical
HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice.
PMID 19662677·J Clin Invest·2009
7-preclinical
Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice.
PMID 19643734·Cancer Res·2009
7-preclinical
Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis.
PMID 19336729·Cancer Prev Res (Phila)·2009
7-preclinical
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.
PMID 18408761·Oncogene·2008
7-preclinical
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance.
PMID 18632637·Cancer Res·2008
7-preclinical
Biodegradable and radically polymerized elastomers with enhanced processing capabilities.
PMID 18689916·Biomed Mater·2008
7-preclinical
Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin.
PMID 18927287·Clin Cancer Res·2008
7-preclinical
An integrated experimental-computational approach for the study of engineered cartilage constructs subjected to combined regimens of hydrostatic pressure and interstitial perfusion.
PMID 19065033·Biomed Mater Eng·2008
7-preclinical
The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model.
PMID 18172549·J Clin Invest·2008
7-preclinical
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.
PMID 19029981·Nat Med·2008
7-preclinical
Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models.
PMID 17510423·Cancer Res·2007
7-preclinical
Immunohistochemical analysis of langerin in langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases.
PMID 17527085·Am J Surg Pathol·2007
8-other
Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy.
PMID 17613438·Cancer Cell·2007
7-preclinical
PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection.
PMID 17911605·J Immunol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 75 FRANCIS ST AMORY 3, BRIGHAM AND WOMENS HOSPITAL DEPARTMENT OF PATHOLOGY
BOSTON, MA 02115 - Phone
- (617) 732-7510
Quick Facts
- NPI
- 1679509640
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile